Business Standard

Monday, December 23, 2024 | 08:16 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Best of BS Opinion: The mis-selling menace, Covid-19 vaccination, and more

Here's a selection of Business Standard opinion pieces for the day

vaccine, vaccination, coronavirus, covid
Premium

Illustration: Binay Sinha

Rajesh Kumar New Delhi
Here's a selection of Business Standard opinion pieces for the day
 
The government announced on Tuesday that it had accepted a recommendation by the National Expert Group that vaccines approved by health regulators in the European Union, the United States, Japan, and the United Kingdom should be granted emergency use approval in India. In this context, our lead editorial notes that having eased requirements, the government’s next step must be to ensure that India’s spare vaccine capacity — it could be producing enough two-shot vaccines a year to inoculate half the world — is pressed into service.
 
After watching the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in